Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiNing Decoction for Radiation Stomatitis
NCT02303197Phase 3Completed
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- May 2014
- Primary completion
- Dec 2015
- Modality
- Botanical, TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ChiNing decoction in oral mucositis (OM) (2 arms), sponsored by Tianjin Medical University Cancer Institute and Hospital. Primary endpoint: Grading standard of RTOG in acute radiation injury of oral mucosal at 8 days. Started May 2014; status: completed.
02
Drugs
ChiNing decoction
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT02303197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303197.